February 5, 2025 - 21:11

A veteran finance executive, Robin Washington has been on Salesforce's board of directors for over a decade. Her extensive experience in financial management and strategic operations positions her as a strong candidate to lead the company’s financial and operational strategies. Washington, who has held senior roles at major corporations, brings a wealth of knowledge in navigating complex financial landscapes.
Her appointment comes at a crucial time for Salesforce as it seeks to enhance its operational efficiency and drive growth in a competitive market. Washington's track record of fostering innovation and implementing effective financial practices is expected to play a pivotal role in the company's future initiatives.
In her new role, she will oversee the company's financial planning, analysis, and reporting, as well as its operational functions. Washington's leadership is anticipated to strengthen Salesforce's commitment to delivering exceptional value to its stakeholders while maintaining its position as a leader in the technology sector.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...